Longeveron Inc. (NASDAQ:LGVN) Shares Shorted: Short Interest Up 114.7% in October

Longeveron Inc. (NASDAQ:LGVN – Get Free Report) was the target of a large increase in short interest in the month of October. As of October 30th, there was short interest totaling 157,139 shares, an increase of 114.7% from the October 15th total of 73,177 shares. Approximately 5.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 72,097 shares, the days-to-cover ratio is currently 2.2 days.

Longeveron Stock Performance

Longeveron stock traded down $0.30 during trading on Monday, reaching $2.19. 26,047 shares of the company’s stock were exchanged, compared to its average volume of 205,709. Longeveron has a 52-week low of $1.31 and a 52-week high of $12.30. The company’s 50-day moving average is $2.92 and its two-hundred day moving average is $6.44. The firm has a market cap of $6.99 million, a price-to-earnings ratio of -0.28 and a beta of -0.09.

Longeveron (NASDAQ:LGVN – Get Free Report) last released its earnings results on Thursday, November 12th. The company reported ($1.91) EPS for the quarter, missing the consensus estimate of ($1.70) by ($0.21). The business had revenue of $0.12 million for the quarter, compared to analysts’ expectations of $0.80 million. Longeveron had a negative net margin of 1,921.72% and a negative return on equity of 243.26%. Analysts anticipate that Longeveron will post -7.20 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts recently weighed in on LGVN shares. Weiss Ratings downgraded shares of Longeveron from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, September 8th. Wall Street Zen downgraded Longeveron from a “hold” rating to a “sell” rating in a research report on Saturday. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $80.00.

Read Our Latest Stock Report on Longeveron

Hedge Funds Weigh In On Longeveron

A hedge fund recently bought a new stake in Longeveron stock. ADAR1 Capital Management LLC purchased a new position in Longeveron Inc. (NASDAQ:LGVN – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 200,000 shares of the company’s stock, valued at approximately $208,000. ADAR1 Capital Management LLC owned approximately 0.86% of Longeveron at the end of the most recent quarter. Institutional investors own 10.01% of the company’s stock.

About Longeveron

(Get Free Report)

Longeveron Inc. is a clinical-stage biotechnology company based in Miami, Florida, developing cell-based therapies for serious and age-related conditions. Its research focuses on medicinal signaling cells, a type of adult stem cell that may influence the body’s repair and immune responses. The company’s lead product candidate, Lomecel-B, is an investigational therapy made from donated bone marrow cells. Longeveron has studied it for conditions including hypoplastic left heart syndrome, Alzheimer’s disease and aging-related frailty.

Further Reading

Receive News & Ratings for Longeveron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longeveron and related companies with MarketBeat.com's FREE daily email newsletter.